Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode (Q24302297)

identical protein binding

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

Thomas W von Geldern

1

0 references

Chunqiu Lai

2

0 references

Rebecca J Gum

3

0 references

Melissa Daly

4

0 references

Chaohong Sun

5

0 references

Elizabeth H Fry

6

0 references

Celerino Abad-Zapatero

Bioorganic & Medicinal Chemistry Letters

7

0 references

language of work or name

English

0 references

publication date

1 April 2006

0 references

published in

0 references

volume

16

0 references

issue

7

0 references

page(s)

1811-5

0 references

cites work

Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Hypoglycaemic effect of AICAriboside in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Impaired regulation of hepatic fructose-1,6-biphosphatase in the New Zealand Obese mouse: an acquired defect

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

A comparison of the effects of diabetes induced with either alloxan or streptozotocin and of starvation on the activities in rat liver of the key enzymes of gluconeogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Inhibition of Fructose-1,6-bisphosphatase by a New Class of Allosteric Effectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Crystallization and preliminary crystallographic data of fructose-1,6-bisphosphatase from human muscle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Gluconeogenesis and related aspects of glycolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021

Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2006.01.015

7 January 2021